FDA clears drug trials to combat systemic CMV.
D000328:Adult; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007262:Infusions, Intravenous; D017387:Investigational New Drug Application; D008297:Male; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D018579:Patient Selection; D014481:United States; D014486:United States Food and Drug Administration
C108940:GEM 132; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense